- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.04. | Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy | ||
| 16.04. | Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel | ||
| 16.04. | Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover | ||
| 15.04. | In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory | ||
| 15.04. | Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough' | ||
| 15.04. | Novartis CEO Vas Narasimhan joins Anthropic's board as biopharma's ties to AI deepen | ||
| 15.04. | Astellas manufacturing chief views reliable supply, bridging research as his production 'north star' | ||
| 15.04. | Teva launches new online schizophrenia community project | ||
| 15.04. | Pfizer recruits former Angel Lucy Liu for latest mission against cancer | ||
| 15.04. | Ionis exec shares method to the Madness after 2026 Drug Name Tournament win | ||
| 14.04. | FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo | ||
| 14.04. | J&J, chasing $100B year, sports immunology 'dual powerhouse' of Tremfya and new launch Icotyde | ||
| 14.04. | Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions | ||
| 14.04. | Pfizer rebuked by FDA for misleading Adcetris ads on Facebook | ||
| 13.04. | Lilly's Jaypirca shows fixed-duration power in 'ambitious' phase 3 CLL trial win | ||
| 13.04. | ViiV launches 'Still Here' campaign aimed at reminding younger people about HIV | ||
| 10.04. | HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety | ||
| 10.04. | Charles River flows into Boston to help AHA bridge cardiovascular health divide | ||
| 10.04. | Starting material sourcing bottlenecks increase US drug shortage risks: report | ||
| 10.04. | Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on | ||
| 10.04. | Envision hires ConcertAI, IQVIA alum Nick Jones as its med comms president | ||
| 10.04. | The top 10 pharma R&D budgets of 2025 | ||
| 10.04. | Bial launches 'Dialogues with Parkinson's' campaign aimed at identifying early symptoms | ||
| 10.04. | Abbott survey finds 'information overload, confusion and cost' affecting health choices in US | ||
| 10.04. | FDA accuses Amneal, BioCorRx of producing 'false and misleading' drug promos |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.